Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment
Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. J P Albertini , P Valensi , B Lormeau , M H Aurousseau , F Ferrière , J R Attali and L Gattegno Laboratory of Biochemistry and Cell Biology, Hôpital Avicenne, Bobigny,...
Saved in:
Published in | Diabetes care Vol. 21; no. 6; pp. 1008 - 1013 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.06.1998
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin
treatment.
J P Albertini ,
P Valensi ,
B Lormeau ,
M H Aurousseau ,
F Ferrière ,
J R Attali and
L Gattegno
Laboratory of Biochemistry and Cell Biology, Hôpital Avicenne, Bobigny, France. jean-paul.albertini@avc.ap-hop-paris.fr
Abstract
OBJECTIVE: To evaluate the effects of a 14-day intensive insulin therapy and short-term improvement of glycemic control on
serum levels of soluble forms of adhesion molecules, i.e., intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion
molecule-1 (sVCAM-1), and E-selectin (sE-selectin) in NIDDM patients with poor glycemic control. RESEARCH DESIGN AND METHODS:
A total of 16 NIDDM patients were compared with 23 healthy subjects (control group) and investigated before and after intensive
insulin treatment. RESULTS: On day 0, sE-selectin and sVCAM-1 levels were significantly higher in NIDDM patients than in nondiabetic
control subjects (median 87, range 63-115; median 544, range 408-797 vs. 58, 43-80; 443, 395-573 ng/ml, respectively) (P <
0.008 in both cases). On day 15, the fall in sE-selectin levels was significant (P < 0.0001) and at a lesser extent in sVCAM-1
levels (64, 48-85; 506, 417-678 ng/ml, respectively); these levels reached values that no longer differed from those of control
subjects (P = 0.23 and 0.15, respectively). Moreover, the fall in sE-selectin was positively associated with the change in
LDL cholesterol and the improvement of glycemia. CONCLUSIONS: In poorly controlled NIDDM patients, sE-selectin levels are
increased and significantly fall to normal after short-term improvement of glycemic control. This suggests that assaying sE-selectin
makes it possible to detect endothelium activation and to follow its reversal with euglycemia. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0149-5992 1935-5548 |
DOI: | 10.2337/diacare.21.6.1008 |